Birmingham, West Midlands -- (SBWIRE) -- 12/05/2013 -- Value Penny Stocks issues special report on Key Energy Services, Inc. (NYSE:KEG), Krispy Kreme Doughnuts (NYSE:KKD), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Dendreon Corporation (NASDAQ:DNDN).
Key Energy Services, Inc. (NYSE:KEG) opened its last trade at the price of $8.00. Its closing price was $8.15 after gaining 1.62% for the day. The company traded with the total volume of 3,821,254 shares, while its average trading volume remained 2.93 million shares. The beta of this stock stands at 2.44. Key Energy Services, Inc. operates as an onshore rig-based well servicing contractor in the United States and internationally. The company offers rig-based services, including the maintenance, work over, and recompletion of existing oil and gas wells.
For How Long KEG will Fight for Profitability? Read This Trend Analysis report
Krispy Kreme Doughnuts (NYSE:KKD) percentage change surged 3.16% to close at $20.21 with the total traded volume of 3,822,928 shares, along with average volume of 1.27 million shares. The 52 week range of the stock remained $8.85 - $26.63, while its day lowest price was $19.58. The share price hit the day highest price of $20.49. Krispy Kreme Doughnuts, Inc., together with its subsidiaries, operates as a branded retailer and wholesaler of doughnuts, beverages, and treats and packaged sweets worldwide. It owns and franchises Krispy Kreme stores.
For How Long KKD’s Gloss will Attract Investors? Find out via this report
Orexigen Therapeutics, Inc. (NASDAQ:OREX) traded on volume of 3,731,795 shares in the last session against average volume of 2.29 million shares. The company started its trading session with the price of $6.10 and closed at $5.99 by scoring -2.12%. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Dendreon Corporation (NASDAQ:DNDN) started its last trading session with the price of $2.96 and closed at $3.05 by scoring +2.69%. The stock traded with total volume of 3,691,034 shares, while the average trading volume remained 4.54 million shares. The beta value of this stock stands at 5.04. Day range for the stock was $2.96 - $3.08. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients. Its product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers.
Why Should Investors Buy DNDN After The Recent Gain? Just Go Here and Find Out
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)